Dabigatran Capsule
Product Images NDC 42291-034

This is a description of a medication called Dabigatran Etexilate in capsule form by AVKARE. The capsules contain 86.48 mg of Dabigatran Etexilate mesylate equivalent to 76 mg of Dabigatran Etexilate. It is essential to swallow the capsule whole and use the product within 4 months once opened. The medication guide should be dispensed with each patient's prescription. It is indicated for prescription-only use and not interchangeable with other dosages or forms of Dabigatran Etexilate. Storage instructions include keeping the capsules in the original packaging at temperatures not exceeding 25°C to protect from moisture. The medication is manufactured for AVKARE in Pulaski, TN, and produced by MSH Pharmaceuticals in Piscataway, NJ. Additional information can be found on AVKARE's website.*

This is a prescription medication called Dabigatran Etexilate in capsule form. Each capsule contains 172.96 mg of dabigatran etexilate, equivalent to 50 mg of dabigatran etexilate. The capsules should be swallowed whole and must be used within 4 months after opening. They are not interchangeable with other dabigatran etexilate dosage forms. The medication should be stored in its original packaging to protect it from moisture and kept tightly closed. Dispensing should be done by a pharmacist according to the provided Medication Guide to each patient. The manufacturer of the medication is AVKARE.*

This text appears to be a list of drug names, dosages, and certain pharmacokinetic parameters such as AUC, Cmax, and fold change with the 90% confidence interval. It also includes a section about "Change Relative to Reference". This information may be related to a study or evaluation of interactions between different drugs and their effects on pharmacokinetic parameters.*